98%
921
2 minutes
20
Introduction: This study aimed to explore the effectiveness of sodium bicarbonate prereduction during continuous veno-venous hemofiltration (CVVH) with regional citrate anticoagulation (RCA).
Methods: Patients undergoing CVVH with RCA were randomly divided into a control group and a prereduction group, with the latter receiving reduced sodium bicarbonate concentration levels to achieve the desired level after three hours of treatment. The investigation focused on variations in pH, bicarbonate ion levels and the frequency of sodium bicarbonate dosage adjustments at different intervals during CVVH.
Results: The 41 participants (20 in the control group, 21 in the prereduction group) treated from July 2023 to February 2024, had no statistically significant differences in demographic or clinical characteristics. The prereduction group demonstrated significantly lower bicarbonate ion levels in the 4th hour (23.62 ± 2.66 mmol/L) compared with the control group (26.57 ± 2.17 mmol/L, P < 0.05) and required fewer bicarbonate adjustments (0 [0,1] times vs. 2 [1,3] times in the control group, P < 0.05).
Conclusion: Sodium bicarbonate prereduction during CVVH using RCA minimises bicarbonate ion fluctuations and reduces the need for dosage adjustments.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000548161 | DOI Listing |
Diabetes Obes Metab
September 2025
Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.
Aim: Sodium-glucose co-transporter-2 inhibitors (SGLT2i) offer significant cardiorenal benefits for people with type 2 diabetes (PwT2D). However, concerns remain regarding their association with diabetes-related ketoacidosis (DKA). (1) To compare demographics, precipitating factors, biochemical features, management, and outcomes of acute DKA admissions between SGLT2i users (n = 267) and non-users (n = 793) with T2D.
View Article and Find Full Text PDFMol Genet Metab Rep
December 2025
Pediatric Critical Care Medicine, Department of Pediatrics NewYork-Presbyterian Morgan Stanley Children's Hospital, Columbia University Medical Center, New York, NY, United States of America.
encodes NADH: ubiquinone oxidoreductase core subunit V1, a key component of mitochondrial Complex 1. Biallelic pathogenic variants in this gene produce a broad and variable phenotypic spectrum in affected individuals, including ophthalmoplegia, developmental delays, brain imaging abnormalities, and recurrent episodes of emesis and lactic acidemia. We report female siblings compound heterozygous for two missense variants (Arg40Gln, Val245Met) in with unusual presentations of this condition.
View Article and Find Full Text PDFISME J
September 2025
Department of Ecology, Environment and Plant Sciences, Stockholm University, Svante Arrhenius väg 20A, SE-106 91 Stockholm, Sweden.
Symbioses between diatoms and the N2-fixing, heterocyst-forming cyanobacterium Richelia spp. are widespread and contribute to primary production. Unique to these symbioses is a variation in the symbiont location: one lives in the host cytoplasm (endobiont) vs.
View Article and Find Full Text PDFBMC Anesthesiol
September 2025
Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Background: Liver transplantation (LT) is a well-known efficacious treatment for life-threatening liver diseases. This complicated surgery is significantly associated with morbidity and mortality. Hyperkalemia (a condition where the blood potassium level is ≥ 5 mEq/L) is a serious complication that occurs at all times during liver transplantation, but it happens more frequently within 5 min after reperfusion.
View Article and Find Full Text PDFCureus
July 2025
Pulmonary and Critical Care, Mercy Medical Center, Festus, USA.
Surviving an arterial pH below 6.5 is exceedingly rare due to significant disruption of processes at the cellular level. We report a case of a 25-year-old female with altered mental status, hypotension, and refractory metabolic acidosis.
View Article and Find Full Text PDF